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During heart development the second heart
field (SHF) provides progenitor cells for most
cardiomyocytes and expresses the homeodo-
main factor Nkx2-5. We now show that feed-
back repression of Bmp2/Smad1 signaling by
Nkx2-5 critically regulates SHF proliferation and
outflow tract (OFT) morphology. In the cardiac
fields of Nkx2-5 mutants, genes controlling car-
diac specification (includingBmp2) and mainte-
nance of the progenitor state were upregulated,
leading initially to progenitor overspecification,
but subsequently to failed SHF proliferation
and OFT truncation. In Smad1 mutants, SHF
proliferation and deployment to the OFT were
increased, while Smad1 deletion in Nkx2-5 mu-
tants rescued SHF proliferation and OFT devel-
opment. In Nkx2-5 hypomorphic mice, which
recapitulate human congenital heart disease
(CHD), OFT anomalies were also rescued by
Smad1 deletion. Our findings demonstrate that
Nkx2-5 orchestrates the transition between
periods of cardiac induction, progenitor prolif-
eration, and OFT morphogenesis via a Smad1-
dependent negative feedback loop, which may
be a frequent molecular target in CHD.
INTRODUCTION
The logic of molecular pathways underpinning heart de-
velopment is poorly understood, and little is known abouthow such pathways are perturbed in congenital heart dis-
ease (CHD). Myocytes of the early heart tube derive from
at least two distinct cardiac progenitor cell populations.
The cardiac crescent and primary heart tube are derived
from cells of the first heart field (FHF) that begin differenti-
ation at the crescent stage. The second heart field (SHF) is
a population of undifferentiated multipotent cardiac pro-
genitor cells that proliferate and contribute dynamically
to heart tube growth at both inflow and outflow poles, pro-
viding the majority of myocytes for the right ventricle (RV)
and outflow tract (OFT), as well as contributions to the left
ventricle (LV) and atria (Buckingham et al., 2005).
A number of factors have been implicated in the devel-
opment of SHF progenitors, including transcription factors
Tbx1, Islet-1 (Isl1), Foxh1, Mef2c, and Hand2, and fibro-
blast growth factors Fgf8 and Fgf10 (Buckingham et al.,
2005). These genes are expressed in SHF cells, and
most are downregulated upon SHF cell differentiation,
suggesting progenitor-specific roles (Kelly, 2005). The T-
box transcription factor Tbx1 is a positive regulator of SHF
proliferation (Xu et al., 2004), potentially via direct control
of genes for fibroblast growth factors Fgf8 and Fgf10
(Hu et al., 2004; Vitelli et al., 2002; Xu et al., 2004). Isl1,
along with Gata4 and Foxh1, controls expression of
Mef2c, a transcription factor essential for specification of
both cardiomyocytes and endothelial lineages (Dodou
et al., 2004; von Both et al., 2004).
The homeodomain factor Nkx2-5 sits high in the cardiac
regulatory hierarchy and is expressed in cells of both the
FHF and SHF (Stanley et al., 2002). The human gene,
NKX2-5, is to date the most commonly mutated single
gene in CHD, accounting for 1%–4% of specific malfor-
mations, including disruption of the interatrial wall (atrial
septal defect; ASD), malpositioning of the outflow vesselsCell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc. 947
(double-outlet right ventricle; DORV), and a complex con-
genital condition arising from stenosis of the pulmonary
artery termed tetralogy of Fallot (Benson et al., 1999; Elliott
et al., 2003; McElhinney et al., 2003; Schott et al., 1998).
Studies in mice show thatNkx2-5 is required for specifica-
tion and spatial definition of chamber myocardium and for
formation and maintenance of elements of the conduction
system (Habets et al., 2002; Jay et al., 2004; Lyons et al.,
1995; Pashmforoush et al., 2004; Tanaka et al., 1999).
However, expression of Nkx2-5 in cardiac progenitor cells
suggests uncharacterized roles for this gene at the earliest
stages of cardiogenesis.
Here we use microarray to compare the transcriptomes
of Nkx2-5 heterozygous and null mutant embryos and
identify an important early role for Nkx2-5 as a negative
regulator of genes responsible for cardiac induction and
the progenitor state. Furthermore, we provide evidence
using Nkx2-5 hypomorphic mice that an Nkx2-5/Bmp2/
Smad1 negative feedback pathway is a molecular target
in CHD.
RESULTS
To map progenitor cell descendants in Nkx2-5 mutant
hearts, we examined expression of region-specific trans-
genes. TheMlc3f-nlacZ-2E transgene normally marks the
LV and right atrium in the looping heart (Figure 1A) (Kelly
et al., 1997), and expression in the single ventricle-like
chamber of Nkx2-5 null embryos (Figure 1B) suggests
that this chamber is a correlate of the normal LV and
mainly derived from the FHF. The narrow, short OFT inmu-
tants was negative for the transgene.
To explore the progenitor composition of mutants fur-
ther, we examined the expression of transgenes Mlc2v-
lacZ, Mef2c-lacZ, and Pitx2c-lacZ that mark the OFT
and RV, derivatives of the anterior SHF (Dodou et al.,
2004; Kelly et al., 2001; Ross et al., 1996; Shiratori et al.,
2001). All transgenes were expressed in the short outflow
region of Nkx2-5 mutant hearts (Figures 1C–1H), showing
that this region contains SHF descendants. The Mlc2v-
lacZ transgene additionally marks a population of SHF-
derived cells at the outflow pole of the LV (Cai et al.,
2003; Ross et al., 1996; Verzi et al., 2005), and expression
was evident at the outflow pole of the ventricle-like cham-
ber in Nkx2-5 mutants (Figures 1C and 1D). This LV SHF
contribution was not highlighted by expression of
Mef2c-lacZ (Figures 1E and 1F), as this transgene is
known to be silenced in LV cells (Verzi et al., 2005).
Pitx2c-lacZ is expressed in descendants of the left ante-
rior SHF that have been exposed to the left/right morpho-
gen nodal (Shiratori et al., 2001), and reduced expression
in the OFT of null embryos (Figures 1G and 1H) confirmed
that the SHF contribution to the heart tube was compro-
mised. Explants from the SHF region of both wild-type
and mutant embryos (Zaffran et al., 2004) expressed
Mlc1v-nlacZ-24, marking the SHF (Kelly et al., 2001) but
not the LV-specific Mlc3f-nlacZ-2E transgene, and this
signature was stable after 48 hr of in vitro culture (data948 Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc.not shown). These data show that both the FHF and
SHF contribute toNkx2-5-null hearts—a primitive LV is es-
tablished relatively normally from FHF progenitors (albeit
with some delay), but the grossly truncated OFT and indis-
tinct RV highlight a prominent SHF defect.
Microarray Profiling of Nkx2-5-Null Hearts
To identify genes dysregulated in the heart and heart fields
of Nkx2-5 mutants, cDNA microarray was performed us-
ing cells purified by fluorescence-activated cell sorting
(FACS) from embryos carrying an Nkx2-5gfp knockin allele
that expresses enhanced green fluorescent protein (GFP)
under Nkx2-5 control (Biben et al., 2000) (Figure 2A).
Sorted cells from single somite-matched embryo pairs
(Nkx2-5gfp/+ versus Nkx2-5gfp/gfp) were compared at nine
Figure 1. Analysis of FHF and SHF Contributions to Nkx2-5-
Null Embryos
(A–H) Expression of indicated lacZ transgenes in wild-type (+/+) and
Nkx2-5gfp/gfp-null (gfp/gfp) embryos at E9.0. The following abbrevia-
tions are used: OFT, outflow tract; LV, left ventricle; LA, left atrium;
RA, right atrium; RV, right ventricle; V, ventricle-like chamber in null
embryos.
Figure 2. Microarray Analysis
(A) Fluorescence channels 1 (Fl1, 530 nM) and 2
(Fl2, 585 nM) FACS plots of wild-type (+/+),
Nkx2-5gfp/+ heterozygous, and Nkx2-5gfp/gfp-
null embryos (both axes log10 scale). Gates
define propidium iodide-permeable dead cells
(dashed line) and live Nkx2-5-GFP+ cells (solid
line). Nkx2-5-GFP+ cells (green) were used for
microarray analysis.
(B) Microarray heat map showing fold change
in mRNA expression between Nkx2-5-null and
heterozygous GFP+ cells (see scale). Genes
modified at least 1.7-fold at three embryonic
stages were clustered by standard correlation
analysis (see tree diagrams for genes, left,
and for embryonic stages, above). Genes
known to be downregulated in Nkx2-5mutants
are arrowed. The prominent cluster of genes
upregulated from 6 to 21 ps is indicated (*).different stages from E8.0 (5 pairs of somites [ps]) to E9.5
(21 ps). Genes with at least a 1.7-fold change in three or
more stages were selected (923 of 16 K unique genes).
Unsupervised hierarchal clustering (Eisen et al., 1998) cor-
rectly ordered all embryonic stages, and known Nkx2-5-
dependent genes were identified (Figure 2B). Myofilament
protein genes were not selected, confirming that cardio-
myocyte differentiation is unaffected in mutants (Lyons
et al., 1995).
Nkx2-5 Negatively Regulates Cardiac
Progenitor Genes
The most numerous and substantial gene-expression
changes were from 15 to 21 ps, with functional annotation
suggesting a preterminal state (see Figure S1 legend). We
assessed earlier stages and saw upregulation of a cohort
of genes from 6 to 21 ps in mutants (Figure 2B). Twenty
genes expressed at 8–12 ps were prioritized using a < 1/
100 false-positive cut-off (Tusher et al., 2001), and their
upregulation was confirmed by quantitative (q) RT-PCR
(Figure S1A) and in situ hybridization (ISH). Region-spe-
cific expression was observed for 9 out of 20 upregulated
genes by ISH. All nine were expressed in cardiac progen-
itor cells, i.e., precardiac mesoderm and the early cres-cent, with all bar one (Tbx5) downregulated in the forming
heart tube. Seven genes were previously unrecognized
markers for cardiac progenitors.
All were expressed, albeit transiently, in the precardiac
region and early cardiac crescent, examples being genes
for insulin-like growth factor binding protein (Igfbp5),
platelet-derived growth factor receptor a (Pdgfra), and
transmembrane protein Odz4 (Figures 3A, 3B, 3E, 3F,
and S2A–S2C). Later patterns identified novel subpopula-
tions within the SHF, e.g., at late crescent stages, genes
for Igfbp5, Pdgfra, and Odz4, as well as matrix protein
tenascin C (Tnc) and homeodomain transcription factor
Pbx3 were expressed most strongly in caudal SHF pro-
genitors (Figures 3A, 3B, 3E, 3F, 3M, 3N, and S2A–S2D).
Anteriorly, Tnc was expressed in the lateral reaches of
SHF mesoderm (wild-type embryos in Figures 3M–3O),
while Pdgfra was expressed more medially in dorsal
mesocardium.
InNkx2-5-null embryos, most of these progenitor genes
failed to undergo downregulation in definitive cardiac
structures; e.g., at E8–8.5 Igfbp5 and Pdgfra expression
persisted throughout the entire early heart tube (Figures
3A–3H). We also examined expression of Pdgfra protein.
In wild-types, expression was seen in the cardiacCell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc. 949
Figure 3. Cardiac Progenitor Genes/
Proteins Upregulated in Nkx2-5-Null
Embryos
(A–X) Whole mount ISH and immunohisto-
chemistry with representative sections show-
ing expression of indicated cardiac progenitor
cell genes/proteins in wild-type (+/+) and
Nkx2-5gfp/gfp embryos at E7.5-E8.5. Regions of
upregulated expression in Nkx2-5 mutants are
indicated (arrows, cardiac mesoderm; arrow-
heads, endoderm).crescent then strongly in caudal progenitors and dorsal
mesocardium (Figures 3I and 3K), resembling the mRNA
pattern (Figures 3E–3G). In null embryos, expression
was seen throughout the heart tube (Figures 3J and 3L).
Expression of Tnc did not persist in the mutant heart
tube but was strikingly upregulated in the dorsal mesocar-
dium and dorsal pericardial SHF mesoderm (Figures
3M–3P).
Isl1 Is a Pan-Cardiac Progenitor Marker Negatively
Regulated by Nkx2-5
We examined expression of SHF marker Isl1, not present
on our arrays. In wild-type embryos Isl1 transcripts were
abundant in the SHF but undetectable in cardiomyocytes
of the crescent and heart tube (Figures 3Q–3S), support-
ing published data (Cai et al., 2003). However, in Nkx2-5-
null embryos, Isl1 expression persisted in cardiomyocytes
of the cardiac crescent and heart tube (Figures 3Q–3T).
By qRT-PCR, Isl1 mRNA was upregulated 4-fold in
FACS-purified GFP+ cells from Nkx2-5gfp/gfp embryos at
6–12 ps (Figure S1A).
In contrast to Isl1 mRNA, Isl1 protein was expressed
in E7.5 wild-type embryos throughout the anterior intra-
embryonic coelomic walls and proximal head mesen-
chyme, regions that encompass both the FHF and SHF
(Figure 3U), as well as in ventral and lateral foregut endo-
derm. Thus, Isl1 is likely to be a pan-cardiac progenitor950 Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc.marker in mouse. By E8.0, Isl1 expression was lost in dif-
ferentiating cardiomyocytes of the late crescent/forming
heart tube (Figure 3W). In Nkx2-5-null embryos, however,
Isl1 levels were increased in anterior coelomic walls and
foregut endoderm at E7.5, and Isl1 persisted in cardio-
myocytes of the late cardiac crescent and heart tube (Fig-
ures 3V and 3X). Expression of Mef2c and Tgfb2, other
SHF genes not present on the array, also persisted in
the heart tube of Nkx2-5 mutants (Figures S2E and S2F).
Quantitative Analysis of Cardiac Progenitor
Phenotype in Nkx2-5-Mutant Embryos
We used the novel cardiac progenitor marker Pdgfra to
perform a quantitative FACS analysis of the persistent
progenitor phenotype seen in Nkx2-5-null hearts. Nkx2-5-
null embryos harbored a2-fold increase in the number of
Nkx2-5-GFP+/Pdgfra+ progenitor cells from 6 to 20 ps
(Figure S3A), attributable to the persistent expression of
Pdgfra in the mutant heart tube (Figures 3E–3L). Impor-
tantly, mean Pdgfra expression per cell was not altered
in Nkx2-5-null embryos (not shown). Other features of
this quantitative analysis were noteworthy. In Nkx2-5gfp/+
controls, both cranial and caudal Nkx2-5-GFP+ SHF
subpopulations were characterized by 5-fold lower
mean levels of Nkx2-5-GFP compared to differentiating
myocytes (Figure S3B). Furthermore, mean GFP ex-
pression per cell was higher in both Nkx2-5-GFP+ and
Figure 4. Overspecification of Cardiac
Progenitors in Nkx2-5-Null Embryos
(A) Percentage ofNkx2-5-GFP+ cells/embryo in
Nkx2-5gfp/+ control and Nkx2-5gfp/gfp-null em-
bryos detected by FACS (6–15 ps). An average
of 7200 cells (6–10 ps) and 23,000 cells (12–
15 ps) were counted for each sample. Asterisks
show significance by chi-square analysis
(***p < 0.001, **p < 0.01, *p < 0.05).
(B–D) GFP mRNA expression in Nkx2-5gfp/+
and Nkx2-5gfp/gfp-null embryos at E7.75 (B)
and E8.5 (C and D). Ectopic Nkx2-5-GFP ex-
pression is indicated in tissues adjacent to the
heart (arrows) and in neural tube (arrowheads).
(E–O) X-gal staining forNkx2-5-lacZ expression
in Nkx2-5lacZ/+ control and Nkx2-5gfp/lacZ-null
embryos at E7.5 (E), E8.0 (F and H–M) and
E9.5 (G,N, and O). Ectopic Nkx2-5-lacZ ex-
pression in the cardiac region (arrows), pharyn-
geal mesenchyme (double arrows), neural tube
(arrowheads), and foregut (double arrowheads)
is indicated. Dashed lines in (F) and (G) indi-
cate planes of sections in H–M and N and O,
respectively.
(P) GFPmRNA expression at E9.0 inNkx2-5gfp/+
and Nkx2-5gfp/gfp embryos showing induction
in neural tube and head mesoderm remote
from the cardiac region in mutants.
(Q and R) Expanded expression of Gata4 at
E8.0 in the medial wall of the intraembryonic
coelom (arrows) in Nkx2-5gfp/gfp embryos.
(S) Expanded expression of Tbx5 at E7.75 in
Nkx2-5gfp/gfp embryos (arrow).Nkx2-5-GFP+/Pdgfra+ cells isolated from mutants com-
pared to heterozygotes (10–20 ps), suggesting that, as
for other progenitor genes, Nkx2-5 is a target of negative
feedback regulation (Figures S3B–S3D).
Nkx2-5 Limits Cardiomyocyte Specification
The data above show that Nkx2-5 is essential for repres-
sing early cardiac progenitor genes. We explored whether
this repressive activity served to limit cardiac specifica-
tion. Assessed by FACS, the number ofNkx2-5-GFP+ cells
was greater in mutants than in heterozygous controls from
6 to 15 ps (Figure 4A). The effect was more pronounced at
earlier stages, with 2-fold more Nkx2-5-GFP+ cells in
mutants at 6–8 ps. ISH using a GFP probe suggested
expansion of Nkx2-5 expression specifically in SHF cells,
i.e., medial to the cardiac crescent at E7.75 and dorso-
lateral and anterior to the heart tube at E8.5 (Figures
4B–4D).
We confirmed an expansion in the number of Nkx2-5-
expressing cells using lacZ staining ofNkx2-5lacZ/+ hetero-
zygous and Nkx2-5gfp/lacZ-null embryos, matched for dos-
age of anNkx2-5-lacZ knockin allele (Elliott et al., 2006). In
null embryos at E8.0 (5 ps), lacZ was more broadly ex-
pressed in mesoderm dorsal to the heart tube at all ante-rior-posterior levels (Figures 4F and 4H–4M). This finding
was not biased by the negative autoregulatory action of
Nkx2-5 that became evident only after 10 ps (Figure S3B).
We examined lacZ expression at the earliest time of its on-
set in anterior lateral plate mesoderm at E7.5 (Figure 4E).
Even at this stage, expression was evident in more cells
in null embryos. Expanded expression of early cardiac
transcription factor markers, Gata4 and Tbx5, in null em-
bryos at E7.75–8.0 (Figures 4Q–4S) confirmed that there
was an expansion of the FHF at early stages in mutants.
Tbx5 was upregulated 2-fold in null embryos at E8.0–8.5
by microarray.
Elevated Bmp2 Signaling in Nkx2-5-Null Embryos
Nkx2-5 was also ectopically expressed in the ventral neu-
ral tube fromE8.75, as detected by ISH forGFP and lacZ
staining in respective mutant strains, an effect that in-
creased dramatically with further development (Figures
4D, 4G, 4N–4P, and S2G). Neural Nkx2-5 expression was
not secondary to a preterminal state because it was ab-
sent in similarly compromised Tbx20lacZ/lacZ-null embryos
(Figure S2H) (Stennard et al., 2005). This suggested the
action of a long-range diffusible morphogen accompany-
ing the increased specification of cardiac progenitorsCell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc. 951
Figure 5. Modified Expression of Cardiac
Signaling Components in Nkx2-5-Null
Embryos
(A–D) Bmp2 expression in wild-type (+/+) and
Nkx2-5gfp/gfp-null embryos at E8.0 (A–C) and
E8.5 (D). Elevated expression in mutants
arrowed.
(E–I) Phospho-Smad1/5/8 expression at E7.75
(E and F) and E8.0 (G–I). Elevated expression
in mutants are indicated in cardiac mesoderm
(single arrows), endoderm (arrowheads), and
ventral neural tube (double arrows).
(J–L) Fgf10 expression at E7.5 (J), E8.5 (K), and
E9.5 (L), arrows showing ectopic expression.
(M–P) b-galactosidase activity from the Mlc1v-
nlacZ-24 transgene at E8.0 (M and N) and
E9.5 (O and P), with arrows showing ectopic
expression.
(Q and R) Coimmunodetection of b-galactosi-
dase protein from the Mlc1v-nlacZ-24 trans-
gene (green nuclei) and sarcomeric myosin
(red) at E7.5 in the cardiac crescent in
Nkx2-5gfp/+ control and Nkx2-5gfp/gfp embryos.
Arrows indicate expanded expression of b-
galactosidase in myosin+ cardiomyocytes in
mutants. (S–V)Hhex expression at E7.75 show-
ing elevated expression in cardiac endoderm
(arrows) and endothelial cells within cranial
mesenchyme (arrowheads) of Nkx2-5gfp/gfp
embryos.
(W and X) Wnt11 expression (arrows) is se-
verely reduced in Nkx-2-5-null embryos at
E7.75 (Y) and E8.5 (Z).in Nkx2-5-null embryos. We therefore examined the ex-
pression of known secreted cardiac-inducing factors.
Bmp2 and Fgf10 mRNAs were elevated in mutant FACS-
purified Nkx2-5-GFP+ cells by microarray and qRT-PCR
(3- to 6-fold and 2- to 15-fold, respectively; Figures S1A
and S1B). By ISH, Bmp2 mRNA was elevated in mutants
in the cardiac crescent (E8.0; Figures 5A–5C) and then
at the pericardial/myocardial boundaries at the poles of
the heart tube (E8.5; Figure 5D). Bmp4 and Bmp7 were
not upregulated. Bmp signaling through Smad1/5/8 phos-
phorylation (pSmad1/5/8) was also increased in mutant
precardiac mesoderm (E7.75; Figures 5E and 5F), then
in the fusing heart tube and SHF (E8.0; Figures 5G–5I). El-
evated phospho-Smad1/5/8 extended to anterior foregut
and visceral endoderm of null mutants (Figures 5E–5I) as
well as to neural ectoderm from E8.0–9.5 (Figures 5H
and 5I). While pSmad was elevated broadly in mutants,
Bmp2 upregulation remained confined to its normal pat-
tern of expression, indicating an enhanced paracrine
and indeed long-range effect of mesoderm-expressed
Bmp2 on endoderm and ectoderm. Expression of genes
encoding Bmp inhibitors, Cer1, Dan, and noggin was not
altered in Nkx2-5 mutants (not shown).
Fgf10 was also upregulated and more broadly ex-
pressed in the cardiac crescent region of Nkx2-5mutants
at E7.5, as seen by ISH (Figure 5J), and expression
persisted throughout themutant heart tube (E8.5–9.5; Fig-
ures 5K and 5L). Fgf8 expression was not elevated952 Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc.(Figure S1B). The Mlc1v-nlacZ-24 transgene traps an
Fgf10 enhancer expressed in the SHF and in its anterior
derivatives, the OFT/RV (Kelly et al., 2001). In mutants,
increased b-galactosidase activity was evident in cardio-
myocytes of the crescent, then whole heart tube at E9.5
(Figures 5M–5P), similar to findings for Fgf10mRNA. Dou-
ble immunostaining of sections from Mlc1v-nlacZ-24
embryos at the late crescent stage showed some overlap
betweenmyosin expression, marking the zone of differen-
tiation in FHF and SHF cells, and lacZ expression, which
marks the SHF. In Nkx2-5 mutants, there was greater en-
croachment of b-galactosidase protein expression into
the FHF in the cranial region (E7.75; Figures 5Q and 5R),
indicating a very early effect on Fgf10.
The homeodomain repressorHhex is expressed in ante-
rior visceral and foregut endoderm and, when overex-
pressed in frog blastomeres, can induce Nkx2-5 expres-
sion in adjacent mesoderm (Foley and Mercola, 2005).
Hhexwas upregulated inNkx2-5mutants in anterior endo-
derm underlying the cardiac crescent (Figures 5S–5V) as
well as in endothelial progenitors within head mesen-
chyme, again suggestive of the action of a long-range
morphogen. Hhexmay be induced in mutants by upregu-
lated Bmp2 via its Smad-responsive enhancer (Zhang
et al., 2002). Expression of Dkk1, encoding a canonical
Wnt inhibitor that can also induce Hhex (Foley and
Mercola, 2005), was unaffected. Cardiogenesis can be
stimulated in frog embryos by the noncanonical Wnt
pathway ligand, Wnt11 (Pandur et al., 2002). However,
Wnt11 was downregulated in mutants (Figures 5W, 5X,
6O, and 6P).
Nkx2-5 Is Required for SHF Proliferation through
Suppression of Bmp2/Smad1 Signaling
Impaired proliferation or deployment of SHF cells may
underpin the dramatically narrowed and shortened OFT
seen in Nkx2-5 mutants. We examined proliferation of
SHF progenitors in mutants, scoring for phosphohistone
H3. As reported (Tanaka et al., 1999, 2001), foregut endo-
derm proliferation showed a reduction by 44% in mutants
(p = 0.011; Figure 6A), but cardiomyocytes were unaf-
fected. However, we also found that proliferation was
strikingly reduced in dorsal pericardial SHF cells (80% re-
duced, p < 0.0001) in the absence of effects on cell death
(not shown).
The Bmp inhibitor noggin stimulates cell proliferation in
chick SHF explants (Waldo et al., 2001). To examine
whether Bmp/Smad signaling represses SHF progenitor
proliferation in vivo, we deleted loxP-flanked (floxed; fl)
Smad1 alleles (Tremblay et al., 2001) specifically in ante-
rior mesoderm, usingMesp1-Cre (Saga et al., 1999). Strik-
ingly, MespCre/+/Smad1fl/fl embryos showed a 2.3-fold in-
crease in proliferation of SHF cells at E8.5 (p < 0.0005;
Figure 6B) but no change inmyocyte proliferation. Prolifer-
ation was unaffected in foregut endoderm (Figure 6B) that
expressed Smad1 (Figure 5H) but not Mesp1-Cre (Saga
et al., 1999), and we conclude, therefore, that the ob-
served effects are not secondary to an altered state of en-
doderm. Consistent with our hypothesis that SHF prolifer-
ation is a driver of OFT/RV morphogenesis, the length (5/7
embryos) or length pluswidth (2/7 embryos) of theOFT/RV
in MespCre/+/Smad1fl/fl hearts was increased at E9.5 (Fig-
ures 6D–6F).
We also assessed whether there was a cell autono-
mous migration defect in Nkx2-5-null SHF cells by exam-
ining their ability to be deployed to the OFT/RV in a com-
petitive situation with wild-type cells in embryo chimeras
(Figure S4). However, we found no evidence for a defect
in this assay.
Genetic Rescue of OFT Formation in Nkx2-5-Null
Embryos
To test genetically whether defective OFT development in
Nkx2-5mutants was due to increased Bmp-Smad signal-
ing, we crossed Nkx2-5 and Smad1mutant mice. Deletion
of one or two Smad1 alleles in Nkx2-5gfp/gfp embryos pro-
duced a progressive increase in SHF proliferation (1.5-
fold, p = 0.059 and 3.1-fold, p = 0.004, respectively, com-
pared to Nkx2-5 nulls; Figure 6C). SHF proliferation in
Nkx2-5/Smad1-double-null embryos was only 23% less
than in wild-type embryos, indicating that most of the anti-
proliferative effect of increased Bmp2 was mediated by
Smad1. We found no precocious differentiation in the
SHF in Nkx2-5 mutants, indicating that the negative ef-
fects of increased Bmp2-Smad1 signaling on SHF prolif-
eration were independent of any prodifferentiative activityof Bmps (Figure S5). Bmp2 remained upregulated at
the pericardial/myocardial boundary in Nkx2-5gfp/gfp/
Smad1/ embryos (Figures 6G–6J), indicating that
Nkx2-5-mediated repression of Bmp2 was independent
of Smad1. However, the ectopic expression of Nkx2-5-
GFP within the head mesenchyme, dorsal foregut, and
neural tube of Nkx2-5 mutants was eliminated by Smad1
deletion (Figures 6K–6N). Therefore, upregulated Bmp2-
Smad1 signaling can account for elevated cardiac speci-
fication and reduced SHF proliferation in Nkx2-5mutants.
We therefore favor the hypothesis that Nkx2-5 acts
indirectly to repress progenitor cell specification and
proliferation.
In the forming heart,Wnt11 expression marks the inflow
and outflow poles (Figures 6O, O0, and O0 0), which are de-
rivatives of the SHF. At E8.5, Smad1/ heart tubes were
truncated and partially bifid (Figures 6Q and Q0 0) (M.J.S.,
M.B.F., and R.P.H., unpublished data). Smad1/ hearts
initially expressedWnt11 throughout most of the myocar-
dium, suggesting that the primary heart tube in this mutant
context is formed predominantly from SHF cells, a possi-
ble result of retarded specification of FHF cells and/or in-
creased SHF proliferation. As shown above, Nkx2-5gfp/gfp
hearts have a highly compromised SHF-derived compo-
nent and accordingly showed downregulatedWnt11 (Fig-
ures 6P, P0, and P0 0). Nkx2-5gfp/gfp/Smad1/ hearts were
also partially bifid, but in striking contrast to Nkx2-5-null
hearts, had greater morphological development of the
outflow region, consistent with improved SHF proliferation
and deployment, and prominent Wnt11-positive outflow
and inflow poles (Figures 6R, R0, and R0 0).
We next explored whether the persistent expression
of cardiac progenitor genes in differentiated myocytes of
Nkx2-5mutants was also Smad1 dependent. Isl1 was un-
detectable in the hearts of Smad1/ embryos but re-
mained upregulated in the hearts of Nkx2-5gfp/gfp/
Smad1/ embryos (Figures 6S–6V). Thus, Nkx2-5 re-
presses cardiacprogenitor genes throughmultiple targets.
The Nkx2-5/Bmp2/Smad1 Negative Feedback Loop
Is a Molecular Target in CHD
We found that our previously established Nkx2-5-IRES-
cre knockin allele (Stanley et al., 2002) produced 50%
less Nkx2-5 protein than a wild-type allele at E8.0 (data
not shown). Nkx2-5+/IRES-cre and Nkx2-5IRES-cre/IRES-cre
mice were grossly normal, but embryos carrying one
Nkx2-5-IRES-cre and one null allele (Nkx2-5gfp/IRES-cre)
were hypomorphic and died postnatally, showing a spec-
trum of cardiac malformations overlapping the more
severe defects seen in humans with NKX2-5 mutations
(Figures 7A–7D). At mid-to-late gestation (E14.5 or E17.5;
n = 29), all hypomorphic hearts showed a ventricular sep-
tal defect (VSD), malrotation of the OFT vessels, and either
DORV or a related condition in which the aorta is posi-
tioned above a VSD (overriding aorta OA; Figures 7A–7D
and 7Q). Similar malformations were seen at birth. Other
frequent abnormalities included interruption of the intera-
trial septum primum (primum ASD), immature or absentCell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc. 953
Figure 6. Nkx2-5 and Smad1 Have Opposing Effects on SHF Proliferation and Deployment
(A–C) Cell proliferation in the SHF of Nkx2-5gfp/gfpmutant versus wild-type control (+/+) embryos (A; E8.0, 6–8 ps, C57BL/6 genetic background) and
embryos deleted for Smad1 in mesoderm (Mesp1Cre/+/Smad1fl/fl) versus heterozygous deleted controls (Mesp1Cre/+/Smad1fl/+) (B; E8.0, 6–8 ps, 75%954 Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc.
mitral and tricuspid valves, and thin-walled ventricles (Fig-
ures 7D and 7Q–7T and Table S2).
Outflow vessel defects seen in Nkx2-5 hypomorphs at
midgestation were predated by OFT defects in earlier
embryos; e.g., the OFT was shorter and thinner and
the RV bulge less prominent at E8.5–9.5 compared to
Nkx2-5+/IRES-cre controls (Figures 7E–7H). These OFT de-
fects may be a less severe manifestation of those seen
in Nkx2-5 nulls. Indeed, at late head-fold stages (E7.75),
Bmp2 and Isl1 expressions were elevated in hypomorphs
(Figures 7I–7K), as wasNkx2-5-IRES-cre expressionmea-
sured by qRT-PCR (1.4-fold increase, p = 0.041), the latter
indicative of cardiac progenitor overspecification. We also
examined proliferation in hypomorphs at E8.5 and found
a decrease in the SHF of 51% but no effect on OFT/RV
cardiomyocytes (Figure 7L; p = 0.024).
Following logic established for null embryos, we asked
whether the OFT/RV defects seen in Nkx2-5 hypomorphs
could be rescued by Smad1 deletion. Deletion of one
Smad1 allele in the germline, or a floxed Smad1 allele
via expression of Cre from the Nkx2-5-IRES-cre allele,
was sufficient to increase the size of the OFT and RV
swelling at E9.5 (Figures 7M and 7N). In conditionally de-
leted Nkx2-5gfp/IRES-cre/Smad1fl/+ embryos at E14.5, mal-
rotation and rightward displacement of the OFT vessels
were largely corrected, and in 11 of 13 cases, the aorta
was correctly oriented leftwards and connected directly
to the LV (p = 0.00024; Table S2 and Figures 7O–7X).
VSD andmitral valve dysmorphogenesis was also less se-
vere in Nkx2-5gfp/IRES-cre hypomorphs with conditionally
deleted Smad1 (p = 0.0022 and p = 0.018, respectively;
Table S2 and Figures 7Q–7X). RV size was also improved
in some embryos (Figures 7O–7X), and in most, matura-
tion of the tricuspid valve was enhanced and an intact
atrial septum was restored, although in isolation these
results did not reach significance (p = 0.053 and p =
0.14, respectively; Table S2). Normal OFT vessel connec-
tions, intact atrial septa, and improved RV size, AV valve
morphology and VSD severity, were also observed in
two Nkx2-5gfp/IRES-cre/Smad1fl/fl embryos recovered at
E14.5.
DISCUSSION
In Nkx2-5 mutants, the upregulation of progenitor signa-
ture genes in the SHF and the abnormal persistence of ex-pression in differentiating myocytes indicate a major early
role for Nkx2-5 in modulating expression of genes asso-
ciated with cardiac induction and progenitor cell status.
The majority of the progenitor genes affected by loss of
Nkx2-5 were expressed in both the FHF and SHF. Expres-
sion in the FHF was extremely transient, reflecting the
early differentiation of these progenitors in the cardiac
crescent. For example, Isl1, previously thought to be
SHF specific, was expressed throughout the intraem-
bryonic coelomic lining at E7.5, which contains compo-
nents of both progenitor fields and is therefore likely to
be a pan-cardiac progenitor cell marker in mice. Transient
FHF Isl1 expression may account for the dearth of marked
FHF descendents in a Cre-fate map (Cai et al., 2003). The
expression patterns of progenitor markers define new
subpopulations and/or their behavioral states. In the
SHF, Tnc, Pdgfra, and Igfbp5were expressed most highly
in caudal cells, while anteriorly, expression of Pdgfra was
restricted to its medial portion (dorsal mesocardium) and
that of Tnc to the most lateral regions. In contrast to skel-
etal muscle development, where proliferation ceases as
differentiation begins and for which there are relatively
clear molecular signatures for progenitors (Pax3/7), myo-
blasts (MyoD, Myf5) and myocytes (myogenin and con-
tractile proteins), cardiac cells continue to proliferate dur-
ing differentiation. It is possible that some of the identified
markers will reflect analogous progressions in the cardiac
lineage, although the distinction between progenitor,
blast, and differentiated states seem less distinct in car-
diac muscle.
An Nkx2-5/Bmp2/Smad1 Negative Regulatory
Circuit Limits Cardiac Specification
We attribute both overspecification and proliferative fail-
ure of cardiac progenitor cells in Nkx2-5 mutants to an
overactive Bmp2/Smad1 pathway. Several observations
suggested involvement of a long-range diffusible morpho-
gen in the spectrum of defects seen inNkx2-5mutants, in-
cluding upregulation of Bmp2 in the cardiac fields and in-
creased levels of phospho-Smad1/5/8 in and beyond the
fields. Bmp2-related factors are cardiac-inducing mole-
cules in vertebrates and invertebrates, with Nkx2-5 and
its Drosophila homolog tinman being direct transcriptional
targets of Bmp-Smads (Liberatore et al., 2002; Lien et al.,
2002). Therefore, an early and possibly direct function for
Nkx2-5 in the cardiac developmental program is toQuackenbush-Swiss/25% C57BL/6) and for littermate embryos from Nkx2-5+/gfp X Smad1+/ crosses (C, E8.5, 10–12 ps, 50%Quackenbush-Swiss/
50% C57BL/6). Shown is the mean percentage of phosphohistone H3+ (pHH3) cells ± standard deviation (SD), n = 3 for each genotype.
(D–F) ISH forWnt11mRNA highlighting increasedOFT/RV (arrows) size inMesp1Cre/+/Smad1fl/fl embryos versusMesp1+/+/Smad1fl/fl andMesp1Cre/+/
Smad1fl/+ controls at E9.5.
(G–V) Marker analysis of wild-type, Nkx2-5-null, Smad1-null, and Nkx2-5/Smad1-double-null littermate embryos for Bmp2 (E8.0; G–J), Nkx2-5-GFP
(E8.25; sections, K–N),Wnt11 (E8.5, ventral views; O–R; right-hand side views, O0–R0; section through OFT, O0 0–R0 0 ), and Isl1 (E8.25, sections; S–V).
Note in Figure 6L the expanded Nkx2-5-GFP expression in the dorsal pericardium (double arrows), adjacent mesenchyme (arrow), dorsal foregut
(arrowhead), and ventral neural tube (double arrowheads) ofNkx2-5-null embryos. In Figures 6O–R0 0 Wnt11 expression is indicated in theOFT (arrows)
and inflow region (arrowheads) of wild-type (O, O0, and O0 0), Smad1-null (Q,Q0, and Q0 0 ), andNkx2-5/Smad1-double-null (R, R0, and R0 0) embryos but is
absent from the rudimentary OFT of Nkx2-5-null embryos (outlined by dotted lines; P, P0, and P0 0). Persistent Isl1 expression in cardiomyocytes
located in the heart tubes of Nkx2-5-null (T) and Nkx2-5/Smad1-double-null (V) embryos is indicated (arrows).Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc. 955
Figure 7. Genetic Rescue of Congenital Cardiac Malformations in Nkx2-5 Hypomorphic Embryos
(A–D) Gross morphology ofNkx2-5 hypomorphic embryos (gfp/IRES-cre) and littermate controls (+/IRES-cre) at E17.5 showing malrotation and right-
ward displacement of the aorta (dashed lines) and pulmonary artery (solid lines) in hypomorphs (A), with sections from E14.5 embryos showing DORV
(C) or OA with large VSD (D).
(E–H) Morphological analysis of early OFT development showing compromised outflow development (arrows) in hypomorphs. Nkx2-5 expression
highlights cardiac structures at E8.5 (E and F). Wnt11 expression marks the RV/OFT at E9.5 (G and H).
(I–K) Molecular analysis of cardiac progenitor cell defects in Nkx2-5gfp/IRES-cre hypomorphic embryos and Nkx2-5+/IRES-cre controls. Note upregulated
expression of cardiac progenitor cell markers Bmp2 (I; E7.75) and Isl1 (J and K; E7.5) in hypomorphs (arrows, precardiac mesoderm; arrowheads,
endoderm).
(L) Decreased proliferation in the SHF ofNkx2-5gfp/IRES-cre hypomorphic embryos (E8.5, 10–12 ps, C57BL/6 genetic background, mean ±SD, n = 3 for
each genotype).
(M–X) Rescue of early OFT defects in Nkx2-5gfp/IRES-cre hypomorphic embryos by deletion of a single allele of Smad1. The immature AV cushions in
hypomorphs are indicated by an asterisk (S and T). The following abbreviations are used: Ao, aortic root; ASD, atrial septal defect; DORV, double
outlet right ventricle; LV, left ventricle; MV, mitral valve; OA, overriding aorta; PA, pulmonary artery; RV, right ventricle; TV, tricuspid valve; VSD, ven-
tricular septal defect.956 Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc.
dampen expression of Bmp2, its immediate upstream
inducer. Preliminary data show that multiple predicted
enhancers of Bmp2 are normally occupied by Nkx2-5 in
cardiac cells, and these warrant further investigation.
The Bmp repressor noggin can stimulate proliferation of
SHF cells in vitro (Waldo et al., 2001), and, as shown here
genetically, Smad1 is a critical negative regulator of SHF
proliferation in vivo. In contrast to the FHF, SHF cells un-
dergo an extended period of mitotic expansion lasting
several days prior to, and overlapping with, their deploy-
ment to the OFT/RV and differentiation. The decreased
proliferation of the SHF in Nkx2-5mutants likely accounts
for the progressive normalization in numbers of Nkx2-5-
GFP+ cells following their initial overspecification. Amodel
for the feedback loop involving Nkx2-5, Bmp2, and
Smad1 and its role in cardiac specification, progenitor
gene expression, and proliferation is presented in Fig-
ure S6. In the context of developmental time, the repres-
sive action of Nkx2-5 on Bmp2/Smad1 orchestrates the
transition between a period of cardiac induction and one
of progenitor proliferation, a negative feedback that is
likely to be a fundamental property of cardiac develop-
mental circuitry in all vertebrates. Given that Nkx2-5 levels
increase from the progenitor to the differentiated state, the
negative feedback pathway may be an example of how
the number of progenitor cells in a field is controlled by
the degree of differentiation—a paradigm that could apply
to adult stem cells and organ regeneration. In this para-
digm, Nkx2-5 acts as both the sensor of differentiation
and as the arbiter of repression. Because the negative
feedback loop balances the number of cardiac progeni-
tors through opposing effects on induction and prolifera-
tion, it is self regulating and thereby shows features of
robustness, an essential component of developmental
systems.
Coexpression of genes defining cardiac progenitor
cells, including Isl1, with cardiomyogenic genes inNkx2-5-
null heart tubes demonstrates that Nkx2-5 also plays
a critical role as a molecular switch in ensuring spatial
and temporal discrimination of the progenitor and differ-
entiating states. However, persistent expression of Isl1
(and presumably other progenitor genes) in the forming
heart tube of Nkx2-5 mutants was not rescued by
Smad1 deletion, suggesting that Nkx2-5-dependent neg-
ative feedback targets multiple sets of genes with distinct
functional consequences for heart development.
A Cardiac Progenitor Cell Defect May Underlie
NKX2-5-Related CHD
The decrease in SHF proliferation in Nkx2-5-null embryos
has potential ramifications for our understanding of hu-
man NKX2-5-related CHD. We describe a hypomorphic
Nkx2-5 model in which animals survived until birth with
a spectrum of cardiac anomalies overlapping themore se-
vere malformations seen in some humans with NKX2-5
mutations. Of note is the high penetrance of OFT defects
accompanied by large VSD in this model. These are not
seen in heterozygous Nkx2-5-null mice (Biben et al.,2000) and are sporadic findings in human patients
(McElhinney et al., 2003), yet are fully penetrant in a hetero-
zygous dominant-negative model of Nkx2-5 deficiency
(Elliott et al., 2006). These findings highlight the fine bal-
ance between the effective activity of Nkx2-5 and CHD
outcome. In humans, the subtle effects of modifier genes
on NKX2-5 levels may explain, in some cases, the variable
phenotypes seen in patients with NKX2-5 mutations.
Our data provide support for correlative evidence that
SHF proliferation is a critical determinant of SHF deploy-
ment and the size andmorphology of the OFT/RV. In chick
embryos, physical ablation of either the SHF or neural
crest, which supports SHF development, leads to a se-
verely decreased contribution of cells to the OFT (Ward
et al., 2005; Yelbuz et al., 2002). This produces abnormal
looping and rightward displacement of the OFT, manifest-
ing later as an OA (Ward et al., 2005; Yelbuz et al., 2002).
Nkx2-5 hypomorphs showed diminished SHF prolifera-
tion, and OFT size and morphology were compromised
as early as E8.5, leading to abnormal displacement of out-
flow vessels to the right, OA, and, in more severe cases,
DORV. These OFT/RV malformations were partially res-
cued by deletion of one or both Smad1 alleles. However,
not all cardiac defects were rescued in Nkx2-5 hypo-
morphs by Smad1 deletion. In particular, small VSDs
and ventricular chamber defects persisted. These are
likely caused by a reduction in chamber differentiation,
in which Nkx2-5 is known to have a direct role (Pashmfor-
oush et al., 2004).
OFT defects are among the most severe cardiac con-
genital malformations and often require surgical interven-
tion in the first year of life. Our study suggests that SHF
genes and those involved in the Nkx2-5/Bmp2/Smad1
negative feedback loop will be molecular targets and
modifiers in CHD. The discovery of this pathway that bal-
ances cardiac progenitor specification and proliferation
now provides a basis for further mechanistic investiga-
tions in this pathological context, as well as in that of the
deployment of stem cells that underlies the formation of
the heart and, eventually, also its repair.
EXPERIMENTAL PROCEDURES
Microarray
Amplified RNA from FACS-sorted Nkx2-5gfp/+ and Nkx2-5gfp/gfp cells
was labeled with Cy3 or Cy5 and hybridized to cDNA arrays. For the
full details (MIAME-compliant) of the clone sets used, array printing,
sample preparation, labelling, and hybridization, see ArrayExpress da-
tabase, accession numbers E-MEXP-533 and -534.
Gene/Protein Expression
Controls used in all experiments were somite-matched littermates. ISH
was as described (Biben and Harvey, 1997). Probes are described in
Table S1. For whole-mount immunohistochemistry, PFA-fixed em-
bryos were treated with acetone for 7 min at 20C, then blocked
for 1 hr in 3% skim milk. For Isl1 and pSmad1, embryos were heated
at 95C for 8 min in unmasking solution (Vector Laboratories) prior to
acetone fixation. Antibodies used were against Pdgfra (APA5, Phar-
Mingen), TER-119 (PharMingen), Isl1 (supernatant 39.4D5, raised
against chick Isl1 C terminus, developed by Thomas Jessell, andCell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc. 957
obtained from the Developmental Studies Hybridoma Bank under the
auspices of the NICHD and maintained by the University of Iowa; and
goat anti-Isl1, raised against full-length human Isl1, GT15051, Neuro-
mics), phospho-Smad1/5/8 (9511S, Cell Signaling), b-galactosidase
(gift from JFNicolas, Pasteur Institute), sarcomericmyosin heavy chain
(MF20, Developmental Studies Hybridoma Bank), and phosphohi-
stone H3 (06-570, Upstate). Quantitative RT-PCR was as described
(Stennard et al., 2005) (primers available on request). For statistical
methods, see figure legends.
Supplemental Data
Supplemental Data include six figures, two tables, and Supplemental
References and can be found with this article online at http://www.
cell.com/cgi/content/full/128/5/947/DC1/.
ACKNOWLEDGMENTS
We thank E. Schmied for technical assistance. Work was supported by
fellowships from the NHMRC (O.W.J.P.), and the Lefoulon-Delalande
(F.B.), and Sasakawa (Y.W.) Foundations, as well as grants (to
R.P.H.) from the NHMRC (354400), NGED, NIH NICHHD (HD047858)
and Johnson & Johnson Focused Giving Program, and (to M.B.)
from the Pasteur Institute, Centre National de la Recherche Scientific
(CNRS), and the EU Integrated Project on Heart Repair. No financial
conflicts of interest.
Received: June 7, 2006
Revised: September 15, 2006
Accepted: January 6, 2007
Published: March 8, 2007
REFERENCES
Benson, D.W., Silberbach, G.M., Kavanaugh-McHugh, A., Cottrill, C.,
Zhang, Y., Riggs, S., Smalls, O., Johnson, M.C., Watson, M.S., Seid-
man, J.G., et al. (1999). Mutations in Nkx2-5, a cardiac transcription
factor affect diverse cardiac developmental pathways. J. Clin. Invest.
104, 1567–1573.
Biben, C., and Harvey, R.P. (1997). Homeodomain factor Nkx2-5 con-
trols left-right asymmetric expression of bHLH eHand during murine
heart development. Genes Dev. 11, 1357–1369.
Biben, C., Weber, R., Kesteven, S., Stanley, E., McDonald, L., Elliott,
D.A., Barnett, L., Koentgen, F., Robb, L., Feneley, M., and Harvey,
R.P. (2000). Cardiac septal and valvular dysmorphogenesis in mice
heterozygous for mutations in the homeobox gene Nkx2-5. Circ.
Res. 87, 888–895.
Buckingham, M., Meilhac, S., and Zaffran, S. (2005). Building the
mammalian heart from two sources of myocardial cells. Nat. Rev.
Genet. 6, 826–835.
Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., and Evans,
S. (2003). Isl1 identifies a cardiac progenitor population that prolifer-
ates prior to differentiation and contributes a majority of cells to the
heart. Dev. Cell 5, 877–889.
Dodou, E., Verzi, M.P., Anderson, J.P., Xu, S.M., and Black, B.L.
(2004). Mef2c is a direct transcriptional target of ISL1 and GATA fac-
tors in the anterior heart field during mouse embryonic development.
Development 131, 3931–3942.
Eisen, M.B., Spellman, P.T., Brown, P.O., and Botstein, D. (1998).
Cluster analysis and display of genome-wide expression patterns.
Proc. Natl. Acad. Sci. USA 95, 14863–14868.
Elliott, D.A., Kirk, E.P., Yeoh, T., Chandar, S., McKenzie, F., Taylor, P.,
Grossfeld, P., Fatkin, D., Jones, O., Hayes, P., et al. (2003). Cardiac
homeobox gene NKX2-5 mutations and congenital heart disease:
associations with atrial septal defect and hypoplastic left heart syn-
drome. J. Am. Coll. Cardiol. 41, 2072–2076.958 Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc.Elliott, D.A., Solloway, M.J., Wise, N., Biben, C., Costa, M.W., Furtado,
M.B., Lange, M., Dunwoodie, S., and Harvey, R.P. (2006). A tyrosine-
rich domain within homeodomain transcription factor Nkx2-5 is an
essential element in the early cardiac transcriptional regulatory ma-
chinery. Development 133, 1311–1322.
Foley, A.C., and Mercola, M. (2005). Heart induction by Wnt antago-
nists depends on the homeodomain transcription factor Hex. Genes
Dev. 19, 387–396.
Habets, P.E., Moorman, A.F., Clout, D.E., van Roon, M.A., Lingbeek,
M., van Lohuizen, M., Campione, M., and Christoffels, V.M. (2002).
Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in
the atrioventricular canal: implications for cardiac chamber formation.
Genes Dev. 16, 1234–1246.
Hu, T., Yamagishi, H., Maeda, J., McAnally, J., Yamagishi, C., and
Srivastava, D. (2004). Tbx1 regulates fibroblast growth factors in the
anterior heart field through a reinforcing autoregulatory loop involving
forkhead transcription factors. Development 131, 5491–5502.
Jay, P.Y., Harris, B.S., Maguire, C.T., Buerger, A., Wakimoto, H.,
Tanaka, M., Kupershmidt, S., Roden, D.M., Schultheiss, T.M., O’Brien,
T.X., et al. (2004). Nkx2-5 mutation causes anatomic hypoplasia of the
cardiac conduction system. J. Clin. Invest. 113, 1130–1137.
Kelly, R.G. (2005). Molecular inroads into the anterior heart field.
Trends Cardiovasc. Med. 15, 51–56.
Kelly, R.G., Zammit, P.S., Schneider, A., Alonso, S., Biben, C., and
Buckingham, M.E. (1997). Embryonic and fetal myogenic programs
act through separate enhancers at the MLC1F/3F locus. Dev. Biol.
187, 183–199.
Kelly, R.G., Brown, N.A., and Buckingham, M.E. (2001). The arterial
pole of the mouse heart forms from Fgf10-expressing cells in pharyn-
geal mesoderm. Dev. Cell 1, 435–440.
Liberatore, C.M., Searcy-Schrick, R.D., Vincent, E.B., and Yutzey, K.E.
(2002). Nkx-2.5 gene induction in mice is mediated by a Smad consen-
sus regulatory region. Dev. Biol. 244, 243–256.
Lien, C.L., McAnally, J., Richardson, J.A., and Olson, E.N. (2002). Car-
diac-specific activity of an Nkx2-5 enhancer requires an evolutionarily
conserved Smad binding site. Dev. Biol. 244, 257–266.
Lyons, I., Parsons, L.M., Hartley, L., Li, R., Andrews, J.E., Robb, L., and
Harvey, R.P. (1995). Myogenic and morphogenetic defects in the heart
tubes of murine embryos lacking the homeobox gene Nkx2-5. Genes
Dev. 9, 1654–1666.
McElhinney, D.B., Geiger, E., Blinder, J., Benson, D.W., and Gold-
muntz, E. (2003). NKX2.5 mutations in patients with congenital heart
disease. J. Am. Coll. Cardiol. 42, 1650–1655.
Pandur, P., Lasche, M., Eisenberg, L.M., and Kuhl, M. (2002). Wnt-11
activation of a non-canonical Wnt signalling pathway is required for
cardiogenesis. Nature 418, 636–641.
Pashmforoush, M., Lu, J.T., Chen, H., Amand, T.S., Kondo, R., Prader-
vand, S., Evans, S.M., Clark, B., Feramisco, J.R., Giles, W., et al.
(2004). Nkx2-5 pathways and congenital heart disease; loss of ventric-
ular myocyte lineage specification leads to progressive cardiomyopa-
thy and complete heart block. Cell 117, 373–386.
Ross, R.S., Navankasattusas, S., Harvey, R.P., and Chien, K.R. (1996).
An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac
ventricular specificity and establishes an anterior-posterior gradient of
expression via an Nkx2-5 independent pathway. Development 122,
1799–1809.
Saga, Y., Miyagawa-Tomita, S., Takagi, A., Kitajima, S., Miyazaki, J.,
and Inoue, T. (1999). MesP1 is expressed in the heart precursor cells
and required for the formation of a single heart tube. Development
126, 3437–3447.
Schott, J.-J., Benson, D.W., Basson, C.T., Pease, W., Silberach, G.M.,
Moak, J.P., Maron, B.J., Seidman, C.E., and Seidman, J.G. (1998).
Congenital heart disease caused by mutations in the transcription
factor NKX2-5. Science 281, 108–111.
Shiratori, H., Sakuma, R., Watanabe, M., Hashiguchi, H., Mochida, K.,
Sakai, Y., Nishino, J., Saijoh, Y., Whitman, M., and Hamada, H. (2001).
Two-step regulation of left-right asymmetric expression of Pitx2:
initiation by nodal signaling and maintenance by Nkx2. Mol. Cell 7,
137–149.
Stanley, E.G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb,
L., and Harvey, R.P. (2002). Efficient Cre-mediated deletion in cardiac
progenitor cells conferred by a 30UTR-ires-Cre allele of the homeobox
gene Nkx2-5. Int. J. Dev. Biol. 46, 431–439.
Stennard, F.A., Costa, M.W., Lai, D., Biben, C., Furtado, M.B., Sollo-
way, M.J., McCulley, D.J., Leimena, C., Preis, J.I., Dunwoodie, S.L.,
et al. (2005). Murine T-box transcription factor Tbx20 acts as a repres-
sor during heart development, and is essential for adult heart integrity,
function and adaptation. Development 132, 2451–2462.
Tanaka, M., Chen, Z., Bartunkova, S., Yamasaki, N., and Izumo, S.
(1999). The cardiac homeobox gene Csx/Nkx2.5 lies genetically
upstream of multiple genes essential for heart development. Develop-
ment 126, 1269–1280.
Tanaka, M., Schinke, M., Liao, H.S., Yamasaki, N., and Izumo, S.
(2001). Nkx2.5 and Nkx2.6, homologs of Drosophila tinman, are re-
quired for development of the pharynx. Mol. Cell. Biol. 21, 4391–4398.
Tremblay, K.D., Dunn, N.R., and Robertson, E.J. (2001). Mouse
embryos lacking Smad1 signals display defects in extra-embryonic
tissues and germ cell formation. Development 128, 3609–3621.
Tusher, V.G., Tibshirani, R., and Chu, G. (2001). Significance analysis
of microarrays applied to the ionizing radiation response. Proc. Natl.
Acad. Sci. USA 98, 5116–5121.
Verzi, M.P., McCulley, D.J., De Val, S., Dodou, E., and Black, B.L.
(2005). The right ventricle, outflow tract, and ventricular septum com-
prise a restricted expression domain within the secondary/anterior
heart field. Dev. Biol. 287, 134–145.Vitelli, F., Taddei, I., Morishima, M., Meyers, E.N., Lindsay, E.A., and
Baldini, A. (2002). A genetic link between Tbx1 and fibroblast growth
factor signaling. Development 129, 4605–4611.
von Both, I., Silvestri, C., Erdemir, T., Lickert, H., Walls, J.R., Henkel-
man, R.M., Rossant, J., Harvey, R.P., Attisano, L., and Wrana, J.L.
(2004). Foxh1 is essential for development of the anterior heart field.
Dev. Cell 7, 331–345.
Waldo, K.L., Kumiski, D.H., Wallis, K.T., Stadt, H.A., Hutson, M.R.,
Platt, D.H., and Kirby, M.L. (2001). Conotruncal myocardium arises
from a secondary heart field. Development 128, 3179–3188.
Ward, C., Stadt, H., Hutson, M., and Kirby, M.L. (2005). Ablation of the
secondary heart field leads to tetralogy of Fallot and pulmonary atresia.
Dev. Biol. 284, 72–83.
Xu, H., Morishima, M., Wylie, J.N., Schwartz, R.J., Bruneau, B.G.,
Lindsay, E.A., and Baldini, A. (2004). Tbx1 has a dual role in the mor-
phogenesis of the cardiac outflow tract. Development 131, 3217–
3227.
Yelbuz, T.M., Waldo, K.L., Kumiski, D.H., Stadt, H.A., Wolfe, R.R.,
Leatherbury, L., and Kirby, M.L. (2002). Shortened outflow tract leads
to altered cardiac looping after neural crest ablation. Circulation 106,
504–510.
Zaffran, S., Kelly, R.G., Meilhac, S.M., Buckingham, M.E., and Brown,
N.A. (2004). Right ventricular myocardium derives from the anterior
heart field. Circ. Res. 95, 261–268.
Zhang, W., Yatskievych, T.A., Cao, X., and Antin, P.B. (2002). Regula-
tion of Hex gene expression by a Smads-dependent signaling path-
way. J. Biol. Chem. 277, 45435–45441.
Accession Numbers
The ArrayExpress accession numbers for themicroarray data reported
in this paper (including theMIAME-compliant details of array construc-
tion and microarray experimental procedures) are E-MEXP-533 and
E-MEXP-534.Cell 128, 947–959, March 9, 2007 ª2007 Elsevier Inc. 959
